David Diamond, PhD discusses Forgotten Baby Syndrome and its impact on vehicular heat stroke fatalities.
David Diamond, PhD discusses Forgotten Baby Syndrome and its impact on vehicular heat stroke fatalities.
FDA extends approval of Evkeeza for homozygous familial hypercholesterolemia in young children
March 22nd 2023Evkeeza is the first angiopoietin-like 3 (ANGPTL3) inhibitor indicated for patients as young at 5 years to control high levels of low-density lipoprotein cholesterol (LDL-C) as a result of HoFH.
2 Clarke Drive
Cranbury, NJ 08512